Selected Drugs Clear All
MultiCheck Results
- 15
Interactions
Avoid/Use Alternative |
||
|
Eliphos
(calcium acetate) + K-Phos Original
(potassium acid phosphate) |
||
Avoid/Use Alternativecalcium acetate + potassium acid phosphate avoid combo or give phosphate 2h before: combo may decr. phosphate efficacy (absorption decreased) |
||
|
Midol Complete
(acetaminophen/ caffeine/ pyrilamine) + Spiriva Respimat
(tiotropium inhaled) |
||
Avoid/Use Alternativepyrilamine + tiotropium inhaled avoid combo: combo may incr. anticholinergic adverse effects (additive effects) |
||
Monitor/Modify Tx |
||
|
Bydureon
(exenatide) + diazoxide
(generic) |
||
Monitor/Modify Txexenatide + diazoxide monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) |
||
|
Bydureon
(exenatide) + Geodon
(ziprasidone) |
||
Monitor/Modify Txexenatide + ziprasidone monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) |
||
|
Bydureon
(exenatide) + Midol Complete
(acetaminophen/ caffeine/ pyrilamine) |
||
Monitor/Modify Txexenatide + acetaminophen give oral acetaminophen at least 1h before twice daily exenatide; caution w/ weekly exenatide: combo may decr. peak acetaminophen levels, delay analgesic onset, efficacy (absorption delayed, possibly decreased) |
||
|
Cardizem CD
(diltiazem) + Co Q10
(coenzyme Q-10) |
||
Monitor/Modify Txdiltiazem + coenzyme Q-10 monitor BP: combo may incr. risk of hypotension (additive effects) |
||
|
Cardizem CD
(diltiazem) + diazoxide
(generic) |
||
Monitor/Modify Txdiltiazem + diazoxide monitor BP: combo may incr. risk of hypotension (additive effects) |
||
|
Cardizem CD
(diltiazem) + Geodon
(ziprasidone) |
||
Monitor/Modify Txdiltiazem + ziprasidone monitor BP: combo may incr. risk of hypotension, incl. orthostasis, syncope (additive effects) |
||
|
Cardizem CD
(diltiazem) + Midol Complete
(acetaminophen/ caffeine/ pyrilamine) |
||
Monitor/Modify Txdiltiazem + caffeine monitor BP; avoid excessive caffeine intake: combo may decr. antihypertensive agent efficacy (antagonistic effects) |
||
|
Co Q10
(coenzyme Q-10) + Geodon
(ziprasidone) |
||
Monitor/Modify Txcoenzyme Q-10 + ziprasidone monitor BP: combo may incr. risk of hypotension, incl. orthostasis, syncope (additive effects) |
||
Caution Advised |
||
|
Bydureon
(exenatide) + K-Phos Original
(potassium acid phosphate) |
||
Caution Advisedexenatide + potassium acid phosphate caution advised w/ solid potassium formulations; liquid potassium formulations OK: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration) |
||
|
Geodon
(ziprasidone) + Midol Complete
(acetaminophen/ caffeine/ pyrilamine) |
||
Caution Advisedziprasidone + pyrilamine caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects) |
||
|
Geodon
(ziprasidone) + Spiriva Respimat
(tiotropium inhaled) |
||
Caution Advisedziprasidone + tiotropium inhaled caution advised: combo may incr. risk of hyperthermia (additive effects) |
||
|
K-Phos Original
(potassium acid phosphate) + Midol Complete
(acetaminophen/ caffeine/ pyrilamine) |
||
Caution Advisedpotassium acid phosphate + pyrilamine caution advised w/ solid potassium formulations; liquid potassium formulations OK: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration) |
||
|
K-Phos Original
(potassium acid phosphate) + Spiriva Respimat
(tiotropium inhaled) |
||
Caution Advisedpotassium acid phosphate + tiotropium inhaled caution advised w/ solid potassium formulations; liquid potassium formulations OK: combo may incr. risk of GI ulcerative, stenotic lesions (GI transit delayed, increased local exposure to high potassium concentration) |
||
Additional Considerations |
||
|
exenatide
in Bydureon
|
||
|
caution advised w/ concurrent oral drugs requiring rapid onset; exenatide delays gastric emptying |
||
|
diltiazem
in Cardizem CD
|
||
|
avoid combo with beverages or products containing ethanol and Cardizem CD, Cartia XT, some generic extended-release (ER) capsules; combo may incr. diltiazem release rate, levels, risk of adverse effects, decr. duration of efficacy |
||
|
hydrogen peroxide topical
in Eskata
|
||
|
Discontinued in US |
||
|
ziprasidone
in Geodon
|
||
|
add MAO inhibitor to Interaction Check if recent (14 days) use |
||
|
calcium acetate
in Eliphos
|
||
|
consider separating administration from other oral drugs w/ narrow therapeutic index; monitor levels as appropriate, clinical response; calcium acetate may decr. absorption of concomitant oral drugs |
||